Department of Cellular and Molecular Pharmacology, The Chicago Medical School at Rosalind Franklin University of Medicine and Science, North Chicago, Illinois.
Biol Psychiatry. 2013 Oct 1;74(7):490-501. doi: 10.1016/j.biopsych.2013.02.021. Epub 2013 Apr 1.
Drug experimentation during adolescence is associated with increased risk of drug addiction relative to any other age group. To further understand the neurobiology underlying such liability, we investigate how early adolescent cocaine experience impacts medial prefrontal cortex (mPFC) network function in adulthood.
A noncontingent administration paradigm was used to assess the impact of early adolescent cocaine treatment (rats; postnatal days [PD] 35-40) on the overall inhibitory regulation of mPFC activity in adulthood (PD 65-75) by means of histochemical and in vivo electrophysiological measures combined with pharmacologic manipulations.
Cocaine exposure during early adolescence yields a distinctive hypermetabolic prefrontal cortex state that was not observed in adult-treated rats (PD 75-80). Local field potential recordings revealed that early adolescent cocaine exposure is associated with an attenuation of mPFC gamma-aminobutyric acid (GABA)ergic inhibition evoked by ventral hippocampal stimulation at beta and gamma frequencies that endures throughout adulthood. Such cocaine-induced mPFC disinhibition was not observed in adult-exposed animals. Furthermore, the normal developmental upregulation of parvalbumin immunoreactivity observed in the mPFC from PD 35 to PD 65 is lacking following early adolescent cocaine treatment.
Our data indicate that repeated cocaine exposure during early adolescence can elicit a state of mPFC disinhibition resulting from a functional impairment of the local prefrontal GABAergic network that endures through adulthood. A lack of acquisition of prefrontal GABAergic function during adolescence could trigger long-term deficits in the mPFC that may increase the susceptibility for the onset of substance abuse and related psychiatric disorders.
与其他任何年龄段相比,青少年期的药物实验与更高的药物成瘾风险相关。为了进一步了解这种易感性的神经生物学基础,我们研究了青少年早期可卡因体验如何影响成年后内侧前额叶皮层(mPFC)的网络功能。
使用非条件给药范式来评估早期青春期可卡因处理(大鼠;出生后第 35-40 天)对成年期(第 65-75 天)mPFC 活动整体抑制调节的影响,方法是结合组织化学和体内电生理测量以及药理学操作。
青春期早期可卡因暴露导致独特的前额叶皮层代谢亢进状态,而在成年期处理的大鼠中未观察到(第 75-80 天)。局部场电位记录显示,青春期早期可卡因暴露与 mPFC 中腹侧海马刺激诱发的 GABA 能抑制的减弱有关,这种抑制在β和γ频率下持续存在,贯穿成年期。在成年期暴露的动物中未观察到这种可卡因诱导的 mPFC 去抑制。此外,在 mPFC 中,从 PD 35 到 PD 65 观察到的 parvalbumin 免疫反应的正常发育性上调在青春期早期可卡因处理后缺失。
我们的数据表明,青春期早期的反复可卡因暴露可引起 mPFC 去抑制状态,这是由于局部前额叶 GABA 能网络的功能障碍所致,这种状态持续到成年期。青春期期间缺乏获得前额叶 GABA 能功能可能会导致 mPFC 的长期缺陷,从而增加物质滥用和相关精神障碍的易感性。